Cargando…

Per2 Upregulation in Circulating Hematopoietic Progenitor Cells During Chronic HIV Infection

Chronic HIV infection accelerates immune aging and is associated with abnormal hemato-lymphopoiesis, but the relationship between HIV-induced aging and Hematopoietic Progenitor Cells (HPC) function is not well-defined. In the context of aging, it has been demonstrated using a murine model that Per2...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordoni, Veronica, Tartaglia, Eleonora, Refolo, Giulia, Sacchi, Alessandra, Grassi, Germana, Antinori, Andrea, Fimia, Gian Maria, Agrati, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396677/
https://www.ncbi.nlm.nih.gov/pubmed/32850472
http://dx.doi.org/10.3389/fcimb.2020.00362
_version_ 1783565637905285120
author Bordoni, Veronica
Tartaglia, Eleonora
Refolo, Giulia
Sacchi, Alessandra
Grassi, Germana
Antinori, Andrea
Fimia, Gian Maria
Agrati, Chiara
author_facet Bordoni, Veronica
Tartaglia, Eleonora
Refolo, Giulia
Sacchi, Alessandra
Grassi, Germana
Antinori, Andrea
Fimia, Gian Maria
Agrati, Chiara
author_sort Bordoni, Veronica
collection PubMed
description Chronic HIV infection accelerates immune aging and is associated with abnormal hemato-lymphopoiesis, but the relationship between HIV-induced aging and Hematopoietic Progenitor Cells (HPC) function is not well-defined. In the context of aging, it has been demonstrated using a murine model that Per2 (Period circadian clock 2) is a negative regulator of HPC survival and lineage potential. A possible involvement of Per2 modulation on hematopoietic failure during HIV infection has not yet been investigated. The aim of this study was to analyze whether Per2 is differently expressed and regulated on HPC during HIV infection, possibly providing a therapeutic target to restore lymphoid potential in the HPC compartment. To this purpose, Per2 expression in circulating HPC was compared in 69 chronic HIV infected patients under successful ART and in matched 30 uninfected healthy donors (HD). HPC aging was assessed by measuring relative telomere length (RTL), and HPC functionality was evaluated by Colony Forming Cell (CFC) assay from both ex vivo HIV+ patients and in vitro Per2 overexpressing donors. Our results showed a lower RTL in HPC and a decrease of white progenitor colonies from HIV+ patients with lower CD4 respect to those with higher CD4 T cell count (<500 respect to >500 CD4 T cell/mmc). Interestingly, we found that the frequency of Per2-expressing HPC is higher in HIV+ patients than in HD and correlated to RTL of CFC derived cells, highlighting a relationship between low proliferative rate and Per2 expression. Indeed, the in vitro overexpression of Per2 resulted in a significant decrease of white progenitor colonies respect to control cells. Finally, we showed that the deacetylase Sirtuin 1, a negative regulator of Per2, was downregulated in HPC from HIV+ patients, and the peripheral blood treatment with resveratrol (Sirtuin 1 inducer) determined a decrease of Per2 expressing HPC. Altogether, these results suggest that during HIV infection, Per2 is involved in the regulation of HPC expansion and differentiation and its overexpression may impair the immune reconstitution. These data support the rationale to explore the role of this regulatory mechanism during aged-associated hemato-lymphopoiesis impairment in HIV infection.
format Online
Article
Text
id pubmed-7396677
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73966772020-08-25 Per2 Upregulation in Circulating Hematopoietic Progenitor Cells During Chronic HIV Infection Bordoni, Veronica Tartaglia, Eleonora Refolo, Giulia Sacchi, Alessandra Grassi, Germana Antinori, Andrea Fimia, Gian Maria Agrati, Chiara Front Cell Infect Microbiol Cellular and Infection Microbiology Chronic HIV infection accelerates immune aging and is associated with abnormal hemato-lymphopoiesis, but the relationship between HIV-induced aging and Hematopoietic Progenitor Cells (HPC) function is not well-defined. In the context of aging, it has been demonstrated using a murine model that Per2 (Period circadian clock 2) is a negative regulator of HPC survival and lineage potential. A possible involvement of Per2 modulation on hematopoietic failure during HIV infection has not yet been investigated. The aim of this study was to analyze whether Per2 is differently expressed and regulated on HPC during HIV infection, possibly providing a therapeutic target to restore lymphoid potential in the HPC compartment. To this purpose, Per2 expression in circulating HPC was compared in 69 chronic HIV infected patients under successful ART and in matched 30 uninfected healthy donors (HD). HPC aging was assessed by measuring relative telomere length (RTL), and HPC functionality was evaluated by Colony Forming Cell (CFC) assay from both ex vivo HIV+ patients and in vitro Per2 overexpressing donors. Our results showed a lower RTL in HPC and a decrease of white progenitor colonies from HIV+ patients with lower CD4 respect to those with higher CD4 T cell count (<500 respect to >500 CD4 T cell/mmc). Interestingly, we found that the frequency of Per2-expressing HPC is higher in HIV+ patients than in HD and correlated to RTL of CFC derived cells, highlighting a relationship between low proliferative rate and Per2 expression. Indeed, the in vitro overexpression of Per2 resulted in a significant decrease of white progenitor colonies respect to control cells. Finally, we showed that the deacetylase Sirtuin 1, a negative regulator of Per2, was downregulated in HPC from HIV+ patients, and the peripheral blood treatment with resveratrol (Sirtuin 1 inducer) determined a decrease of Per2 expressing HPC. Altogether, these results suggest that during HIV infection, Per2 is involved in the regulation of HPC expansion and differentiation and its overexpression may impair the immune reconstitution. These data support the rationale to explore the role of this regulatory mechanism during aged-associated hemato-lymphopoiesis impairment in HIV infection. Frontiers Media S.A. 2020-07-21 /pmc/articles/PMC7396677/ /pubmed/32850472 http://dx.doi.org/10.3389/fcimb.2020.00362 Text en Copyright © 2020 Bordoni, Tartaglia, Refolo, Sacchi, Grassi, Antinori, Fimia and Agrati. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Bordoni, Veronica
Tartaglia, Eleonora
Refolo, Giulia
Sacchi, Alessandra
Grassi, Germana
Antinori, Andrea
Fimia, Gian Maria
Agrati, Chiara
Per2 Upregulation in Circulating Hematopoietic Progenitor Cells During Chronic HIV Infection
title Per2 Upregulation in Circulating Hematopoietic Progenitor Cells During Chronic HIV Infection
title_full Per2 Upregulation in Circulating Hematopoietic Progenitor Cells During Chronic HIV Infection
title_fullStr Per2 Upregulation in Circulating Hematopoietic Progenitor Cells During Chronic HIV Infection
title_full_unstemmed Per2 Upregulation in Circulating Hematopoietic Progenitor Cells During Chronic HIV Infection
title_short Per2 Upregulation in Circulating Hematopoietic Progenitor Cells During Chronic HIV Infection
title_sort per2 upregulation in circulating hematopoietic progenitor cells during chronic hiv infection
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396677/
https://www.ncbi.nlm.nih.gov/pubmed/32850472
http://dx.doi.org/10.3389/fcimb.2020.00362
work_keys_str_mv AT bordoniveronica per2upregulationincirculatinghematopoieticprogenitorcellsduringchronichivinfection
AT tartagliaeleonora per2upregulationincirculatinghematopoieticprogenitorcellsduringchronichivinfection
AT refologiulia per2upregulationincirculatinghematopoieticprogenitorcellsduringchronichivinfection
AT sacchialessandra per2upregulationincirculatinghematopoieticprogenitorcellsduringchronichivinfection
AT grassigermana per2upregulationincirculatinghematopoieticprogenitorcellsduringchronichivinfection
AT antinoriandrea per2upregulationincirculatinghematopoieticprogenitorcellsduringchronichivinfection
AT fimiagianmaria per2upregulationincirculatinghematopoieticprogenitorcellsduringchronichivinfection
AT agratichiara per2upregulationincirculatinghematopoieticprogenitorcellsduringchronichivinfection